Stroke risk factors and outcomes among hospitalized women with atrial fibrillation

被引:0
|
作者
Gregory Piazza
Shelley Hurwitz
Samuel Z. Goldhaber
机构
[1] Brigham and Women’s Hospital,Division of Cardiovascular Medicine, Department of Medicine
[2] Harvard Medical School,Division of Infectious Diseases, Department of Medicine
[3] Brigham and Women’s Hospital,Division of Cardiovascular Medicine, Department of Medicine
[4] Harvard Medical School,undefined
[5] Brigham and Women’s Hospital,undefined
[6] Harvard Medical School,undefined
来源
Journal of Thrombosis and Thrombolysis | 2021年 / 52卷
关键词
Anticoagulation; Antithrombotic therapy; Atrial fibrillation; Gender; Sex; Stroke;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1023 / 1031
页数:8
相关论文
共 50 条
  • [31] Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation
    Wiesholzer, M
    Harm, F
    Tomasec, G
    Barbieri, G
    Putz, D
    Balcke, P
    AMERICAN JOURNAL OF NEPHROLOGY, 2001, 21 (01) : 35 - 39
  • [32] Gender differences in comorbidities and risk factors in ischemic stroke patients with a history of atrial fibrillation
    Rathfoot, Chase
    Edrissi, Camron
    Sanders, Carolyn Breauna
    Knisely, Krista
    Poupore, Nicolas
    Nathaniel, Thomas
    BMC NEUROLOGY, 2021, 21 (01)
  • [33] Gender Differences in Anticoagulation and Stroke Outcomes in Atrial Fibrillation
    Kassim, Natasha A.
    Qin, Dingxin
    Richards, Thomas
    Leef, George
    Saba, Samir
    CIRCULATION, 2015, 132
  • [34] Risk of Stroke Outcomes in Atrial Fibrillation Patients Treated with Rivaroxaban and Warfarin
    Milentijevic, Dejan
    Lin, Jennifer H.
    Connolly, Nancy
    Chen, Yen-Wen
    Kogan, Emily
    Shrivastava, Shubham
    Sjoeland, Erik
    Alberts, Mark J.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2021, 30 (05)
  • [35] Risk Factors for Stroke and Thromboembolism in Relation to Age Among Patients With Atrial Fibrillation The Loire Valley Atrial Fibrillation Project
    Olesen, Jonas Bjerring
    Fauchier, Laurent
    Lane, Deirdre A.
    Taillandier, Sophie
    Lip, Gregory Y. H.
    CHEST, 2012, 141 (01) : 147 - 153
  • [36] Social and psychological risk factors for decreased adherence among patients with atrial fibrillation
    Troshina, Daria V.
    Andreev, Denis A.
    Fomicheva, Anastasia V.
    Volovchenko, Alexey N.
    Volel, Beatrice A.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (10) : 1197 - 1203
  • [37] Influence of Competing Risks on the Association Between Warfarin and Ischemic Stroke in Atrial Fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
    Ashburner, Jeffrey M.
    Go, Alan S.
    Chang, Yuchiao
    Fang, Margaret C.
    Fredman, Lisa
    Applebaum, Katie M.
    Singer, Daniel E.
    CIRCULATION, 2015, 132
  • [38] Novel Oral Anticoagulant Use Among Patients With Atrial Fibrillation Hospitalized With Ischemic Stroke or Transient Ischemic Attack
    Patel, Priyesh A.
    Zhao, Xin
    Fonarow, Gregg C.
    Lytle, Barbara L.
    Smith, Eric E.
    Xian, Ying
    Bhatt, Deepak L.
    Peterson, Eric D.
    Schwamm, Lee H.
    Hernandez, Adrian F.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2015, 8 (04): : 383 - 392
  • [39] Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin
    Vinereanu, Dragos
    Lopes, Renato D.
    Mulder, Hillary
    Gersh, Bernard J.
    Hanna, Michael
    de Barros e Silva, Pedro G. M.
    Atar, Dan
    Wallentin, Lars
    Granger, Christopher B.
    Alexander, John H.
    STROKE, 2017, 48 (12) : 3266 - 3273
  • [40] Warfarin persistence among stroke patients with atrial fibrillation
    Bjorck, Fredrik
    Renlund, Henrik
    Svensson, Peter J.
    Sjalander, Anders
    THROMBOSIS RESEARCH, 2015, 136 (04) : 744 - 748